Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Post by whisky11on Apr 13, 2021 12:14pm
256 Views
Post# 32985436

L2.. Hopefully the volume will go up ,maybe after 3 PM

L2.. Hopefully the volume will go up ,maybe after 3 PM
I think that last interview with
Dr. Salzman if it was aired at BNN Bloomberg then we see
50 million shares volume and $0.50 stock price


Level II Quotes
Orders
Shares
Bid
Ask
Shares
Orders
6
118,000
0.05
0.055
577,000
7
14
623,000
0.045
0.06
216,000
5
24
1,599,000
0.04
0.065
357,000
4
10
2,037,000
0.035
0.07
557,000
6
7
2,249,000
0.03
0.075
157,000
4

CLASCLARITAS PHARMACCA
$ 0.055
0.005
(10.00%)
Bid (Size)
0.05 (118)
Ask (Size)
0.055 (577)
Volume
40,302

<< Previous
Bullboard Posts
Next >>